BIT
IPCI

BlackRock Institutional Trust’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

BlackRock Institutional Trust’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,375
Closed -$54K – 3924
2014
Q4 		$54K Hold
2,375
– – ﹤0.01% 3762
2014
Q3 		$71K Buy
+2,375
New +$68.5K ﹤0.01% 3694

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock Institutional Trust's IPCI Position: Q1 2015 in Review

BlackRock Institutional Trust sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2015, closing a stake of 2,375 shares — an estimated $54K sold.

BlackRock Institutional Trust first reported a position in IPCI in Q3 2014 and held it in 2 quarters. The position peaked at $71K in Q3 2014. 19 funds tracked by Wall St. Rank hold IPCI as of Q1 2015.

  • BlackRock Institutional Trust reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 2,375 Intellipharmaceuticals International Inc. shares in Q1 2015, an estimated $54K.
  • BlackRock Institutional Trust first reported a position in Intellipharmaceuticals International Inc. in Q3 2014 and held it in 2 quarters.
  • BlackRock Institutional Trust's Intellipharmaceuticals International Inc. position peaked at $71K in Q3 2014.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2015.

Based on BlackRock Institutional Trust's 13F filing for Q1 2015, filed 13 May 2015.